Citrulline, Lycopene, and Cardiovascular Health

Evidence Review

RCT: Watermelon and Aortic Blood Pressure (Figueroa et al., 2014)

This double-blind, crossover RCT enrolled 13 middle-aged adults with stage 1 hypertension and obesity (mean age 58, BMI ≥ 30). Participants received either watermelon extract (providing 6g citrulline + 4g arginine daily) or a placebo for six weeks, then crossed over after a washout period. The primary outcome was aortic blood pressure response to the cold pressor test (CPT), a standardized cardiovascular stress challenge that exposes subclinical arterial stiffness not captured by resting blood pressure.

After watermelon supplementation, aortic systolic blood pressure during CPT was significantly reduced (mean reduction 8 mmHg, p < 0.05) compared to placebo. Carotid-femoral pulse wave velocity — a direct measure of arterial stiffness — was also significantly improved. Brachial blood pressure at rest showed a trend toward reduction but did not reach statistical significance, underscoring that aortic stiffness and stress-response blood pressure are more sensitive endpoints. Strengths: double-blind crossover design, objective hemodynamic endpoints. Limitations: very small sample (13 participants), short duration (6 weeks), used extract rather than whole fruit [1].

Review: Citrulline and Vascular Function (Figueroa et al., 2017)

This narrative review synthesized available human trial data on L-citrulline and watermelon supplementation through 2016. The review identified consistent evidence that watermelon-derived citrulline increases plasma arginine concentrations more effectively than equivalent doses of arginine alone, due to superior bioavailability via avoidance of first-pass splanchnic extraction. Studies in hypertensive, obese, and post-menopausal women populations showed consistent reductions in brachial and aortic systolic blood pressure (ranging 6–15 mmHg in responsive populations), as well as improvements in flow-mediated dilation — a measure of endothelial function — of approximately 1–3 percentage points [2].

The review also noted that citrulline's exercise performance effects were more mixed, with benefits more consistently seen for recovery and reduction of perceived exertion than for acute performance enhancement. Doses equivalent to two to three cups of watermelon daily appeared sufficient for cardiovascular effects.

Systematic Review: Cardio-Metabolic Health 2000–2020 (Burton-Freeman et al., 2021)

This review in Current Atherosclerosis Reports synthesized twenty years of evidence on watermelon and L-citrulline across multiple cardiovascular and metabolic outcomes. The authors found consistent mechanistic evidence that citrulline increases plasma arginine and NO production, with most trials showing clinically meaningful blood pressure reductions in populations with elevated baseline pressure. The bioavailability advantage of watermelon-derived citrulline over supplemental arginine was confirmed across multiple pharmacokinetic studies [3].

Beyond blood pressure, evidence was identified for improvements in lipid oxidation, endothelial function, and — in some studies — body composition and insulin sensitivity, though these findings were less consistent and often confounded by the broader anti-inflammatory and nutrient profile of the whole food. The review highlighted that most trials were small (n = 10–50) and of short duration (4–12 weeks), calling for larger, longer trials powered to detect effects on clinical cardiovascular events.

RCT: Watermelon Juice and Muscle Soreness (Tarazona-Díaz et al., 2013)

This triple-blind RCT enrolled seven trained male cyclists and assigned them to three conditions in a crossover design: natural watermelon juice, watermelon juice enriched with additional citrulline (to match supplemental citrulline doses used in other studies), or a non-watermelon placebo drink. Each participant performed a maximal cycling effort after consuming their assigned drink one hour prior, and muscle soreness was assessed at 24 hours post-exercise using a validated soreness scale.

Both watermelon juice groups reported significantly less muscle soreness (p < 0.05) compared to the placebo group at 24 hours. Heart rate recovery one hour after exercise was also significantly better in both watermelon groups. Interestingly, the natural watermelon juice and the citrulline-enriched juice performed similarly — suggesting that the whole-food context did not add additional benefit over citrulline alone once a threshold dose was reached, though the natural juice provided sufficient citrulline for the effect [4]. Limitations: very small sample size (n = 7), elite athletes only (results may not generalize), subjective pain scale as primary endpoint.

Animal Study: Antioxidant and Anti-inflammatory Effects (Hong et al., 2015)

This controlled animal experiment fed rats an atherogenic (cholesterol-raising) diet with or without watermelon supplementation over eight weeks, assessing markers of inflammation and antioxidant capacity. The watermelon group showed significantly higher activity of superoxide dismutase and catalase — the body's primary enzymatic antioxidants — and significantly lower levels of malondialdehyde, a marker of lipid peroxidation and oxidative stress. Inflammatory cytokines including TNF-alpha and IL-6 were also significantly lower in the watermelon group [5].

While animal studies cannot be directly extrapolated to humans, the mechanisms identified — lycopene-driven antioxidant enzyme upregulation and reduction of pro-inflammatory cytokines — are biologically plausible and consistent with observational data in humans linking lycopene intake to reduced inflammatory markers. The atherogenic diet model is a standard approach for studying cardiovascular disease prevention in rodents.

Cochrane Review: Lycopene and Prostate Cancer (Ilic et al., 2011)

This Cochrane systematic review searched for randomized trials investigating lycopene supplementation or lycopene-rich foods and prostate cancer risk or outcomes. The review identified that while multiple large observational cohorts showed inverse associations between lycopene intake and prostate cancer incidence (with risk reductions in the 10–35% range in highest vs. lowest intake quartiles), the available randomized trial evidence at the time was insufficient to confirm or refute a protective effect [6]. Mechanistic studies suggest lycopene acts through inhibition of insulin-like growth factor signaling, induction of cancer cell apoptosis, and reduction of oxidative DNA damage in prostate tissue.

Evidence Strength Summary

The evidence for watermelon's cardiovascular effects — specifically blood pressure reduction and arterial stiffness improvement via citrulline — is supported by a plausible and well-characterized mechanism (citrulline → arginine → nitric oxide → vasodilation), multiple small RCTs showing consistent directional effects, and a comprehensive systematic review confirming the pattern across two decades of research. The primary limitation is that most trials are small and short-term, and trials powered to detect reduction in cardiovascular events do not exist for watermelon specifically. The lycopene evidence is primarily observational, with mechanistic plausibility but limited causal evidence from trials. The muscle soreness data is intriguing but based on very small athlete samples. Overall, watermelon represents a low-risk, high-enjoyment functional food with credible evidence for blood pressure support and antioxidant defense — making it a reasonable regular inclusion in a cardiovascular-protective diet.